Navigation Links
Reportlinker Adds Epidemiology: Lupus
Date:4/26/2011

NEW YORK, April 26, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Epidemiology: Lupus

http://www.reportlinker.com/p0484924/Epidemiology-Lupus.html

In 2010, Datamonitor estimates that there were about 404,300 prevalent cases of systemic lupus erythematosus (SLE) in the seven major markets, with approximately 80-90% of these cases in women between 45 and 64 years of age. The number of prevalent cases is expected to increase to approximately 420,000 cases by 2020.Gain insight to market potential, including a robust 10-year epidemiology forecast of prevalent systemic lupus erythematosus cases.Understand the key epidemiologic risk factors associated with systemic lupus erythematosus.Between 2010 and 2020, Datamonitor expects to see an overall increase in the number of prevalent cases of systemic lupus erythematosus in the US, France, Spain, and the UK. The largest increase is expected in the US. This is due to the fact that the population in women aged 45-64 is increasing in these countries.A decrease in prevalent cases of systemic lupus erythematosus is expected in Japan, Germany, and Italy. The largest decrease is expected in Japan. This is due to the fact that the population in women aged 45-64 is decreasing in these countries, along with the population on the whole.Women aged between 45 and 64 are expected to constitute approximately 80-90% of cases of systemic lupus erythematosus.What are the most robust sources for systemic lupus erythematosus prevalence?How will the patient population change of the next decade in the US, Japan, and the five major EU markets (France, Germany, Italy, Spain, and the UK)?How do changes in population structure and risk factors affect the trend in prevalent systemic lupus erythematosus cases?

Executive Summary

Risk factors

Epidemiologic forecast

OVERVIEW

Catalyst

Summary

DISEASE DEFINITION AND DIAGNOSIS CRITERIA

Diagnosis criteria

MANIFESTATION OF DISEASE

Arthritis

Cutaneous symptoms

Lupus nephritis

Central nervous system

Vasculitis

GLOBAL VARIATION AND HISTORICAL TRENDS

Morbidity and mortality

Incidence

Prevalence

RISK FACTORS

Race and ethnicity

Gender

Age

Genetics

Environment

CO-MORBIDITIES

Cardiovascular diseases

Bacterial infections

EPIDEMIOLOGIC FORECASTING

Sources of epidemiologic data

Description of methods

US

Japan

France

Germany

Italy

Spain

UK

EPIDEMIOLOGIC RESULTS

Current prevalent cases and future trends

Annual growth rate of disease population

DISCUSSION

Strengths and limitations of Datamonitor's epidemiologic projections

BIBLIOGRAPHY

Journal papers

Websites

Datamonitor reports

APPENDIX

Module methodology

To order this report:

: Epidemiology: Lupus

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Epidemiology: Prostate Cancer
2. Reportlinker Adds Medical Equipment Monthly Deals Analysis - M&A and Investment Trends, April 2011
3. Reportlinker Adds Body Contouring Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4. Reportlinker Adds Ophthalmology DrugFutures
5. Reportlinker Adds Europe ENT Devices Market Outlook to 2017
6. Reportlinker Adds Medical Equipment Annual Deals Analysis 2011
7. Reportlinker Adds Gastric Cancer Drug Discoveries: what the future holds
8. Reportlinker Adds the Drug-Eluting Stent Market Outlook to 2016
9. Reportlinker Adds Successful Strategies for Drug Repositioning
10. Reportlinker Adds Middle Eastern Medical Device Market: Facts and Figures2011
11. Reportlinker Adds Levosimendan - Comprehensive patent search
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):